Alzheimer Research Forum is a nonprofit organization that seeks to advance Alzheimer’s disease research by improving scientists’ access to information and research resources. The forum maintains an extensive web-based metajournal of scientific research, discussion forums, resource indexes, grant/conferences/job opportunities, researcher, lab and institute profiles, and sponsors programs and workshops to address impediments to research.

A free membership allows researchers to:

  • Be found by colleagues and potential collaborators
  • Sign up for our weekly Email Newsletter
  • Post comments on Papers of the Week citations
  • Receive special-interest email notices about events, grants, live discussions and more
  • Create a member profile for the edification of colleagues

So join the forum and sign up now at!

The European Medical Information Framework (EMIF)
EMIF ( is an Innovative Medicines Initiative (IMI) programme, operating under agreement number 115372, and is in year four of five of its funded phase.
EMIF is currently extending access to the EMIF Data Catalogue to researchers beyond EMIF within the research community, linked to its mission of improving identification, access and assessment, and (re)use of health data within the European Union. Information about the access to EMIF Catalogue can be found in this document.

The National Alzheimer's Coordinating Center (NACC)
The NACC was established by the National Institute on Aging (U01 AG016976) in 1999 to facilitate collaborative research. Using data collected from the 29 NIA-funded Alzheimer's Disease Centers (ADCs) across the United States, NACC has developed and maintains a large relational database of standardized clinical and neuropathological research data. In partnership with the Alzheimer's Disease Genetics Consortium (ADGC) and the National Cell Repository for Alzheimer's Disease (NCRAD), NACC provides a valuable resource for both exploratory and explanatory Alzheimer's disease research. NACC data are freely available to all researchers.

Edar Study
The EDAR study is a European collaborative study which aims to develop and validate new biomarkers for Alzheimer’s disease.

Alzheimer Europe

Alzheimer's Disease Cooperative Study (ADCS)

McGill Centre for Studies in Aging (Canada)

Consortium of Canadian Centres for Clinical Cognitive Research

European Alzheimer Clearing House

Alzheimer's Disease Education and Referral (ADEAR) Center

Elder Care Online

Alzheimer's-specific Oral Health Advice

International Academy Nutrition and Aging

National Institute on Aging